Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 7383

BillFederalHouseIn Committee
To amend the Federal Food, Drug, and Cosmetic Act to set forth limitations on exclusive approval or licensure of drugs designated for rare diseases or conditions.
About This Bill
Committee
Latest Action · February 16, 2024
Referred to the Subcommittee on Health.
Introduced
February 15, 2024
Cosponsors (2)
0D 2R
View PDF ↗
SummaryFull TextCommentsAnnotations

Annotations on Text

0 annotations · Highlight text on the Summary or Full Text tab to add one
No annotations yet. Highlight a passage of the text to add one.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.